381 related articles for article (PubMed ID: 25592062)
1. The emerging role of microRNAs in resistance to lung cancer treatments.
MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs Change the Landscape of Cancer Resistance.
Zhu J; Zhu W; Wu W
Methods Mol Biol; 2018; 1699():83-89. PubMed ID: 29086370
[TBL] [Abstract][Full Text] [Related]
3. Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.
Rolfo C; Fanale D; Hong DS; Tsimberidou AM; Piha-Paul SA; Pauwels P; Van Meerbeeck JP; Caruso S; Bazan V; Cicero G; Russo A; Giovannetti E
Curr Pharm Biotechnol; 2014; 15(5):475-85. PubMed ID: 24846062
[TBL] [Abstract][Full Text] [Related]
4. microRNA regulation of cell viability and drug sensitivity in lung cancer.
Du L; Pertsemlidis A
Expert Opin Biol Ther; 2012 Sep; 12(9):1221-39. PubMed ID: 22731874
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer.
Chen Y; Gao Y; Zhang K; Li C; Pan Y; Chen J; Wang R; Chen L
Cell Physiol Biochem; 2015; 37(5):1869-80. PubMed ID: 26584286
[TBL] [Abstract][Full Text] [Related]
7. The Roles of microRNAs in Regulating Chemotherapy Resistance of Non-Small Cell Lung Cancer.
Wei X; Shen X; Ren Y; Hu W
Curr Pharm Des; 2018 Feb; 23(39):5983-5988. PubMed ID: 29046142
[TBL] [Abstract][Full Text] [Related]
8. miRNAs in lung cancer: large roles for small players.
Cherni I; Weiss GJ
Future Oncol; 2011 Sep; 7(9):1045-55. PubMed ID: 21919692
[TBL] [Abstract][Full Text] [Related]
9. Targeting microRNAs to modulate TRAIL-induced apoptosis of cancer cells.
Lu T; Shao N; Ji C
Cancer Gene Ther; 2013 Jan; 20(1):33-7. PubMed ID: 23138871
[TBL] [Abstract][Full Text] [Related]
10. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
[TBL] [Abstract][Full Text] [Related]
11. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
12. The role of microRNA in resistance to breast cancer therapy.
Robertson NM; Yigit MV
Wiley Interdiscip Rev RNA; 2014; 5(6):823-33. PubMed ID: 25044299
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ
Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
[TBL] [Abstract][Full Text] [Related]
14. miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
Catuogno S; Cerchia L; Romano G; Pognonec P; Condorelli G; de Franciscis V
Oncogene; 2013 Jan; 32(3):341-51. PubMed ID: 22370637
[TBL] [Abstract][Full Text] [Related]
15. The roles of microRNA in cancer and apoptosis.
Lynam-Lennon N; Maher SG; Reynolds JV
Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
[TBL] [Abstract][Full Text] [Related]
16. microRNAs as pharmacological targets in cancer.
Soriano A; Jubierre L; Almazán-Moga A; Molist C; Roma J; de Toledo JS; Gallego S; Segura MF
Pharmacol Res; 2013 Sep; 75():3-14. PubMed ID: 23537752
[TBL] [Abstract][Full Text] [Related]
17. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as therapeutic targets in chemoresistance.
Garofalo M; Croce CM
Drug Resist Updat; 2013; 16(3-5):47-59. PubMed ID: 23757365
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
20. Targeting the MET gene for the treatment of non-small-cell lung cancer.
Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M
Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]